Cargando…
The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia
BACKGROUND: Hemodialysis (HD) patients with functional iron deficiency often develop resistance to recombinant human erythropoietin (rhEPO). Recent studies have shown that intravenous ascorbic acid (IVAA) administration could override rhEPO resistance in HD patients. This study was undertaken to tes...
Autores principales: | Kang, Dae Woong, Ahn, Chi Yong, Ryu, Bong Kwan, Shin, Byung Chul, Chung, Jong Hoon, Kim, Hyun Lee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715092/ https://www.ncbi.nlm.nih.gov/pubmed/26889408 http://dx.doi.org/10.1016/j.krcp.2012.01.002 |
Ejemplares similares
-
Role of Intravenous Ascorbic Acid in the Management of Anemia in Hemodialysis Patients
por: El Shinnawy, Howayda, et al.
Publicado: (2021) -
Effect of short-term intravenous ascorbic acid on reducing ferritin in hemodialysis patients
por: Jalalzadeh, M., et al.
Publicado: (2012) -
Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients
por: Lee, Wan Soo, et al.
Publicado: (2015) -
Comparative Study of Intravenous Iron Versus Intravenous Ascorbic Acid for Treatment of Functional Iron Deficiency in Patients Under Hemodialysis: A Randomized Clinical Trial
por: Sedighi, Omid, et al.
Publicado: (2013) -
Economic Benefits of Switching From Intravenous to Subcutaneous
Epoetin Alfa for the Management of Anemia in Hemodialysis
Patients
por: Prasad, Bhanu, et al.
Publicado: (2020)